NCT00796159已完成不适用
A Post Marketing Surveillance, Multicenter, Open-Label, Dose-Titrating, 4-Week Study Evaluating The Efficacy, Tolerability And Safety Of Olmesartan Medoxomil 20mg In Combination With 12.5mg Hydrochlorothiazide In Subjects With Stage 1 To Stage 2 Hypertension
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Pfizer
- 入组人数
- 1,723
- 主要终点
- Safety (Adverse Events)
研究概览
简要总结
This is a Post-Marketing Surveillance study evaluating the Efficacy, Tolerability and Safety of Olmesartan medoxomil 20 mg in combination with 12.5 MG of hydrochlorothiazide in subjects with mild to moderate essential hypertension
详细描述
Non Probability Sampling
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male and Female patients 18 to 65 y/old
- •Patient previously taking low-dose medoxomil or any other ARB alone with uncontrolled BP
- •Patient with uncontrolled mild to moderate hypertension (SBP>= 140 and <=179 mmHg OR DBP of >=90 and <=109 mmHg)
排除标准
- •Pregnant of Lactating women
- •History of secondary hypertension
研究组 & 干预措施
Olmesartan medoxomil + HCTZ
干预措施: Olmesartan medoxomil (Drug)
结局指标
主要结局
Safety (Adverse Events)
时间窗: 4 weeks
次要结局
- Blood Pressure(4 weeks)
研究者
相似试验
终止
不适用
Linagliptin Among Filipino Patients With Type 2 Diabetes MellitusDiabetes Mellitus, Type 2NCT01826370Boehringer Ingelheim678
终止
不适用
A Post Marketing Surveillance Study to Assess the Safety and Efficacy of Cetuximab Plus Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and NeckUnresectable Locally Advanced Squamous Cell Carcinoma of Head and NeckLA SCCHNNCT01303237Merck KGaA, Darmstadt, Germany88
已完成
不适用
A Postmarketing Surveillance (PMS) Study to Evaluate the Extent to Which Patient Compliance is Influenced by Use of a Variable Titration Regimen at the Start of Treatment of Relapsing Multiple Sclerosis (MS) With Interferon Beta 1a (Rebif®)Relapsing-Remitting Multiple SclerosisNCT01142492Merck KGaA, Darmstadt, Germany403
已完成
4 期
Safety of Haemophilus Influenza Type b Vaccine When Administered to Korean ChildrenHaemophilus Influenzae Type B InfectionNCT01404962Novartis Vaccines764
撤回
4 期
Travacom Post Marketing Surveillance StudyOcular HypertensionOpen-angle GlaucomaNCT01510132Alcon Research